Publications

I have published 40 + papers in peer-reviewed journals on the topics of tuberculosis, sepsis, antimicrobial resistance, malaria and more, as well as book chapters, including the “Tuberculosis – A comprehensive clinical reference” (2009), and reports for the World Health Organization, the Norwegian public health institute and the Norwegian Health directorate.

Publications [1-43], book chapters, various publications: [44-53]

  1. Jensenius M, Winje BA, Blomberg B, Mengshoel AT, von der Lippe B, Hannula R, Bruun J, Knudsen PK, Ronning JO, Heldal E, Dyrhol Riise AM: Multidrug-resistant tuberculosis in Norway: a nationwide study, 1995-2014. International Journal of Tuberculosis and Lung Disease 2016, (Accepted for publication).
  2. Haaskjold YL, Bolkan HA, Krogh KO, Jongopi J, Lundeby KM, Mellesmo S, Garces PSJ, Josendal O, Opstad A, Svensen E, et al: Clinical features and risk factors for adverse outcome in Ebola virus disease in Moyamba District, Sierra Leone. (Submitted) 2016.
  3. Aamodt H, Mohn SC, Maselle S, Manji KP, Willems R, Jureen R, Langeland N, Blomberg B: Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children. BMC Infectious Diseases 2015, 15:107.
  4. Tellevik MG, Moyo SJ, Blomberg B, Hjollo T, Maselle SY, Langeland N, Hanevik K: Prevalence of Cryptosporidium parvum/hominis, Entamoeba histolytica and Giardia lamblia among Young Children with and without Diarrhea in Dar es Salaam, Tanzania. PLoS Negl Trop Dis 2015, 9:e0004125.
  5. Onken A, Said AK, Jorstad M, Jenum PA, Blomberg B: Prevalence and Antimicrobial Resistance of Microbes Causing Bloodstream Infections in Unguja, Zanzibar. PLoS One 2015, 10:e0145632.
  6. Moyo S, Haldorsen B, Aboud S, Blomberg B, Maselle SY, Sundsfjord A, Langeland N, Samuelsen O: Identification of VIM-2-Producing Pseudomonas aeruginosa from Tanzania Is Associated with Sequence Types 244 and 640 and the Location of blaVIM-2 in a TniC Integron. Antimicrob Agents Chemother 2015, 59:682-685.
  7. Heggheim A, Blomberg B, Morch K: Preparedness for severe malaria. Tidsskr Nor Laegeforen 2015, 135:533-535.
  8. Strom GE, Tellevik MG, Hanevik K, Langeland N, Blomberg B: Comparison of four methods for extracting DNA from dried blood on filter paper for PCR targeting the mitochondrial Plasmodium genome. Trans R Soc Trop Med Hyg 2014, 108:488-494.
  9. Strom GE, Moyo S, Fataki M, Langeland N, Blomberg B: PCR targeting Plasmodium mitochondrial genome of DNA extracted from dried blood on filter paper compared to whole blood. Malar J 2014, 13:137.
  10. Spjeldnaes AO, Kitua AY, Blomberg B: Education and knowledge helps combating malaria, but not degedege: a cross-sectional study in Rufiji, Tanzania. Malar J 2014, 13:200.
  11. Moyo SJ, Hanevik K, Blomberg B, Kommedal O, Nordbo SA, Maselle S, Langeland N: Prevalence and molecular characterisation of human adenovirus in diarrhoeic children in Tanzania; a case control study. BMC Infect Dis 2014, 14:666.
  12. Moyo SJ, Blomberg B, Hanevik K, Kommedal O, Vainio K, Maselle SY, Langeland N: Genetic diversity of circulating rotavirus strains in Tanzania prior to the introduction of vaccination. PLoS One 2014, 9:e97562.
  13. Moyo SJ, Aboud S, Blomberg B, Mkopi N, Kasubi M, Manji K, Lyamuya EF, Maselle SY, Langeland N: High nasal carriage of methicillin-resistant Staphylococcus aureus among healthy Tanzanian under-5 children. Microb Drug Resist 2014, 20:82-88.
  14. Moyo S, Hanevik K, Blomberg B, Kommedal O, Vainio K, Maselle S, Langeland N: Genetic diversity of norovirus in hospitalised diarrhoeic children and asymptomatic controls in Dar es Salaam, Tanzania. Infect Genet Evol 2014, 26:340-347.
  15. Strom GE, Tellevik MG, Fataki M, Langeland N, Blomberg B: No asymptomatic malaria parasitaemia found among 108 young children at one health facility in Dar es Salaam, Tanzania. Malar J 2013, 12:417.
  16. Strom GE, Haanshuus CG, Fataki M, Langeland N, Blomberg B: Challenges in diagnosing paediatric malaria in Dar es Salaam, Tanzania. Malar J 2013, 12:228.
  17. Haanshuus CG, Mohn SC, Morch K, Langeland N, Blomberg B, Hanevik K: A novel, single-amplification PCR targeting mitochondrial genome highly sensitive and specific in diagnosing malaria among returned travellers in Bergen, Norway. Malar J 2013, 12:26.
  18. Haug JB, Berild D, Blomberg B, Bruun JN, Flaatten HK, Leiva RA, Skrede S, Torfoss D, Undseth O: [Aminoglycosides in severe sepsis]. Tidsskr Nor Laegeforen 2013, 133:1553-1554.
  19. Ali C, Strom A, Blomberg B: [Increased understanding is the key in the fight against genital mutilation]. Tidsskr Nor Laegeforen 2013, 133:1559.
  20. Power OA, Brun JG, Blomberg B: [A woman in her thirties with pain in her fingers and toes]. Tidsskr Nor Laegeforen 2012, 132:2401-2403.
  21. Moyo SJ, Steinbakk M, Aboud S, Mkopi N, Kasubi M, Blomberg B, Manji K, Lyamuya EF, Maselle SY, Langeland N: Penicillin resistance and serotype distribution of Streptococcus pneumoniae in nasopharyngeal carrier children under-5 years in Dar es Salaam, Tanzania. J Med Microbiol 2012.
  22. Arnaud L, Hervier B, Neel A, Hamidou MA, Kahn JE, Wechsler B, Perez-Pastor G, Blomberg B, Fuzibet JG, Dubourguet F, et al: CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood 2011, 117:2778-2782.
  23. Dyrhol-Riise AM, Gran G, Wentzel-Larsen T, Blomberg B, Haanshuus CG, Morkve O: Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis 2010, 10:57.
  24. Blomberg B, Langeland N: Tuberculous meningitis and resistance to isoniazid. BMJ 2010, 341:c4677.
  25. Blomberg B: [Antimicrobial resistance in developing countries]. Tidsskr Nor Laegeforen 2008, 128:2462-2466.
  26. Berg A, Patel S, Langeland N, Blomberg B: Falciparum malaria and HIV-1 in hospitalized adults in Maputo, Mozambique: does HIV-infection obscure the malaria diagnosis? Malar J 2008, 7:252.
  27. Tellevik MG, Sollid JE, Blomberg B, Jureen R, Urassa WK, Langeland N: Extended-spectrum beta-lactamase-type SHV-12-producing Enterobacteriaceae causing septicemia in Tanzanian children: vectors for horizontal transfer of antimicrobial resistance. Diagn Microbiol Infect Dis 2007, 59:351-354.
  28. Hoftvedt BO, Thorleifsson E, Hagestad K, Blomberg B, Rogde S, Nedal A: Fra kooperasjon til kapitalisme [From cooperation to capitalism]. Tidsskr Nor Laegeforen 2007, 127:68-70.
  29. Blomberg B, Manji KP, Urassa WK, Tamim BS, Mwakagile DS, Jureen R, Msangi V, Tellevik MG, Holberg-Petersen M, Harthug S, et al: Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study. BMC Infect Dis 2007, 7:43.
  30. Blomberg B, Olsen BE, Hinderaker SG, Langeland N, Gasheka P, Jureen R, Kvale G, Midtvedt T: Antimicrobial resistance in urinary bacterial isolates from pregnant women in rural Tanzania: implications for public health. Scand J Infect Dis 2005, 37:262-268.
  31. Blomberg B, Jureen R, Manji KP, Tamim BS, Mwakagile DS, Urassa WK, Fataki M, Msangi V, Tellevik MG, Maselle SY, Langeland N: High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania. J Clin Microbiol 2005, 43:745-749.
  32. Vaagland H, Blomberg B, Kruger C, Naman N, Jureen R, Langeland N: Nosocomial outbreak of neonatal Salmonella enterica serotype Enteritidis meningitis in a rural hospital in northern Tanzania. BMC Infect Dis 2004, 4:35.
  33. Panchagnula R, Agrawal S, Ashokraj Y, Varma M, Sateesh K, Bhardwaj V, Bedi S, Gulati I, Parmar J, Kaul CL, et al: Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspective. Methods Find Exp Clin Pharmacol 2004, 26:703-721.
  34. Blomberg B, Mwakagile DS, Urassa WK, Maselle SY, Mashurano M, Digranes A, Harthug S, Langeland N: Surveillance of antimicrobial resistance at a tertiary hospital in Tanzania. BMC Public Health 2004, 4:45.
  35. Strand TA, Hollingshead SK, Julshamn K, Briles DE, Blomberg B, Sommerfelt H: Effects of zinc deficiency and pneumococcal surface protein a immunization on zinc status and the risk of severe infection in mice. Infect Immun 2003, 71:2009-2013.
  36. Blomberg B, Fourie B: Fixed-dose combination drugs for tuberculosis: application in standardised treatment regimens. Drugs 2003, 63:535-553.
  37. Blomberg B: A memorable patient: An aunt without health insurance [Filler]. Br Med J 2003, 326:279.
  38. Blomberg B, Rieder HL, Enarson DA: Kristian Andvord’s impact on the understanding of tuberculosis epidemiology. Int J Tuberc Lung Dis 2002, 6:557-559.
  39. Andvord KF, Wijsmuller G, Blomberg B: What can we learn by following the development of tuberculosis from one generation to another? 1930. Int J Tuberc Lung Dis 2002, 6:562-568.
  40. Blomberg B, Spinaci S, Fourie B, Laing R: The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis. Bull World Health Organ 2001, 79:61-68.
  41. Sbarbaro J, Blomberg B, Chaulet P: Fixed-dose combination formulations for tuberculosis treatment. Int J Tuberc Lung Dis 1999, 3:S286-288.
  42. Norval PY, Blomberg B, Kitler ME, Dye C, Spinaci S: Estimate of the global market for rifampicin-containing fixed-dose combination tablets. Int J Tuberc Lung Dis 1999, 3:S292-300; discussion S317-221.
  43. Blomberg B, Kitler ME, Milstien J, Dellepiane N, Fanning A, Norval PY, Spinaci S: Availability of quality fixed-dose combinations for the treatment of tuberculosis: what can we learn from studying the World Health Organization’s vaccine model? Int J Tuberc Lung Dis 1999, 3:S371-380; discussion S381-377.
  44. Blomberg B, Flaatten HK, Skrede S: Sepsis. In Norsk legemiddelhåndbok for helsepersonell 2013 (Norwegian medicinal products handbook for health personnel 2013). Oslo: Foreningen for utgivelse av Norsk legemiddelhåndbok; 2013
  45. Chapter on Sepsis in National guidelines for use of antimicrobial drugs in hospitals. Norwegian Directorate of Health; 2013.
  46. Blomberg B: Management of side effects of antituberculosis drugs (Book Chapter). In Tuberculosis – A Comprehensive Clinical Reference. Edited by Schaaf HS, Zumla AI: Elsevier; 2009
  47. Rysstad O, Blomberg B, Holtmon L, Severinsen G, Mørkve O, Thorsrud A, Brantsæter A, Mannsåker T, Winje B, Furuseth E, Sandbu S: Report on the use of BCG vaccine in Norway (Rapport 2008:12 Utredning om bruk av BCG-vaksine i Norge). Oslo: Norwegian Institute of Public Health; 2008.
  48. Blomberg B, Langland N: HIV treatment in low-income countries – responsibility of the western world? (Newspaper article) (HIV behandling i fattige land – den vestlige verdens ansvar? (Kronikk). In Bergens Tidende2007.
  49. Blomberg B, Evans P, Phanouvong S, Nunn P: Informal consultation on 4-drug fixed-dose combinations compliant with the WHO Model List of Essential Drugs. Geneva, Switzerland, 15-17 August 2001. Geneva: UNDP, World Bank, WHO Special Programme for Research & Training in Tropical Diseases (TDR); 2002.
  50. Blomberg B: Frequently asked questions about the 4-drug fixed-dose combination tablet recommended by the World Health Organization for treating tuberculosis. (WHO ed. Geneva: Global Drug Facility, Stop TB partnership, World Health Organization; 2002.
  51. Blomberg B: Fake medicines, a threat to human health (newspaper letter). In The Guardian. pp. 6. Dar es Salaam, Tanzania2001:6.
  52. Blomberg B, Maher D, Spinaci S: Rational use of drugs in the treatment of tuberculosis (Book Chapter). In International experience in rational use of drugs. Volume 3. Edited by Chaudhury RR. Bangkok: College of Public Health, Chulalongkorn University, Bangkok/UNESCO Chair in rational use of drugs; 2000: 128-165
  53. Laing R, Fourie B, Ellard G, Sesay M, Spinaci S, Blomberg B, Bryant D: World Health Organization. Fixed dose combination tablets for the treatment of tuberculosis. Report from an informal meeting held in Geneva, Tuesday, 27 April 1999. pp. 1-43. Geneva: World Health Organization; 1999:1-43.